PTPI (Petros Pharmaceuticals) Beginning Cash Position: $5.14 Mil (As of Mar. 2026)


What is Petros Pharmaceuticals Beginning Cash Position?

Petros Pharmaceuticals PTPI +6.52% Beginning Cash Position is $5.14 Mil as of Mar. 2026.

Petros Pharmaceuticals's Beginning Cash Position for the quarter that ended in Mar. 2026 was $5.14 Mil.

Petros Pharmaceuticals's quarterly Beginning Cash Position declined from Sep. 2025 ($7.32 Mil) to Dec. 2025 ($6.07 Mil) and declined from Dec. 2025 ($6.07 Mil) to Mar. 2026 ($5.14 Mil).

Petros Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2023 ($9.43 Mil) to Dec. 2024 ($13.34 Mil) but then declined from Dec. 2024 ($13.34 Mil) to Dec. 2025 ($3.71 Mil).

Petros Pharmaceuticals Beginning Cash Position Related Terms

Petros Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Petros Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petros Pharmaceuticals Beginning Cash Position Chart

Petros Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 17.14 23.85 9.43 13.34 3.71

Petros Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.71 10.76 7.32 6.07 5.14

Petros Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $5.14 Mil mean?
Petros Pharmaceuticals (PTPI) has a Beginning Cash Position of $5.14 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Petros Pharmaceuticals and its competitors.
Is Petros Pharmaceuticals' Beginning Cash Position too high?
Petros Pharmaceuticals' current Beginning Cash Position is $5.14 Mil.
How does Petros Pharmaceuticals' Beginning Cash Position compare to STEK and KOAN?
Petros Pharmaceuticals' Beginning Cash Position of $5.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Petros Pharmaceuticals and its competitors. Petros Pharmaceuticals's current Beginning Cash Position is $5.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petros Pharmaceuticals stock overvalued right now?
Petros Pharmaceuticals (PTPI) has a current Beginning Cash Position of $5.14 Mil. The current Beginning Cash Position is $5.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Petros Pharmaceuticals (PTPI), the current Beginning Cash Position is $5.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petros Pharmaceuticals Business Description

Address 1185 Avenue of the Americas, 3rd Floor, New York, NY, USA, 10036
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.